Patient with a prosthetic valve (by type)

Know the valve, have a baseline, then separate stenosis, patient–prosthesis mismatch, high flow, thrombus and pannus.

Echo approach, step by step

Prosthetic valve assessment starts before the probe: know the type, size and implant date, and have the baseline study [21,167]. A baseline TTE should be recorded after implantation (within weeks to 3 months); every later study is compared with it [7,21,167].

  1. IdentifyMechanical (bileaflet, tilting disc, caged ball) or biological (stented, stentless, homograft, transcatheter); size; position [21,167].
  2. Record BSA, BP and HRGradients depend on flow and rate [21].
  3. 2DSewing ring stability (rocking), leaflet or occluder motion, thickening, calcification, masses [167].
  4. Aortic prosthesis DopplerVmax, mean gradient, EOA (continuity), DVI, acceleration time and AT/ET [21,167].
  5. Mitral prosthesis DopplerE, mean gradient at the recorded HR, PHT, EOA, VTI-PrMV / VTI-LVOT [21,167].
  6. RegurgitationTransvalvular versus paravalvular. For TAVI, the circumferential extent of paravalvular jets in short axis [20,167].
  7. PPMIndexed EOA against the published normal value for that model and size [93,107].
  8. EscalateTOE for mitral prostheses (acoustic shadowing), endocarditis and thrombosis; fluoroscopy for mechanical leaflet motion; CT for pannus or leaflet thrombosis (HALT) [167,212].

Causes & echo clues

Types of prosthesis and what normal looks like [21,167]

TypeNormal appearance and Doppler
Bileaflet mechanicalTwo leaflets, three orifices; small normal "washing" jets at the hinges; localised high velocity in the central orifice (pressure recovery)
Tilting discSingle disc, major and minor orifice; a small central or peripheral washing jet
Caged ballHigh gradients are normal; ball motion within the cage
Stented bioprosthesisThin, mobile cusps; gradients similar to a mild native AS
Stentless / homograftLow gradients; resembles the native root
Transcatheter (TAVI)Frame visible; lower gradients with supra-annular self-expanding valves; mild paravalvular leaks are common

High gradient: why? [21,167]

MechanismEOADVI (aortic)AT (aortic)Clue
Obstruction (thrombus, pannus, degeneration)Low<0.25>100 msRestricted leaflets; rising versus baseline
Patient–prosthesis mismatchLow EOAi but normal for this model and sizeNormalNormalUnchanged from the baseline study
High flow (anaemia, fever, AR)NormalNormalNormalHigh LVOT VTI
Pressure recovery (small bileaflet valves)NormalNormalNormalDoppler exceeds catheter gradient
Mitral: significant MR through the prosthesisApparently low——High VTI ratio with normal PHT

Clinical pathway to the diagnosis

  1. Symptoms, INR history and haemolysis tests(LDH, haptoglobin, reticulocytes).
  2. TTE compared with the baseline[21,167].
  3. Stenosis patternDifferentiate thrombus from pannus. Thrombus favours a short history, subtherapeutic INR and a soft, larger mass. Pannus favours a long history and a dense, small subvalvular mass. Use TOE, fluoroscopy and CT [167,212].
  4. Mechanical valve thrombosisManagement depends on whether the valve is obstructed, the patient's condition, thrombus size and surgical risk: optimise anticoagulation, give slow-infusion thrombolysis, or operate [6,167].
  5. Bioprosthetic thrombosisAnticoagulation often reverses it [6,167].
  6. SurveillanceACC/AHA 2020: TTE for surgical bioprostheses at 5 and 10 years and then annually; annually after TAVI; earlier with symptoms [7].

Clinical pearls & pitfalls

PitfallMitral prosthesis regurgitation is often hidden by acoustic shadowing on TTE. Indirect signs (high E, VTI ratio >2.5 with normal PHT, unexplained raised PASP) should prompt TOE [21,167].

Red flags